NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFκB activation

Olivier Calvayrac, Ricardo Rodríguez-Calvo, Ingrid Martí-Pamies, Judith Alonso, Beatriz Ferrán, Silvia Aguiló, Javier Crespo, Antonio Rodríguez-Sinovas, Cristina Rodríguez, José Martínez-González

    Research output: Contribution to journalArticleResearchpeer-review

    32 Citations (Scopus)


    © 2014 Elsevier Ltd. Recent work has highlighted the role of NR4A receptors in atherosclerosis and inflammation. In vascular smooth muscle cell (VSMC) proliferation, however, NOR-1 (neuron-derived orphan receptor-1) exerts antagonistic effects to Nur77 and Nurr1. The aim of this study was to analyse the effect of NOR-1 in VSMC inflammatory response. We assessed the consequence of a gain-of-function of this receptor on the response of VSMC to inflammatory stimuli. In human VSMC, lentiviral over-expression of NOR-1 reduced lipopolysaccharide (LPS)-induced up-regulation of cytokines (IL-1β, IL-6 and IL-8) and chemokines (MCP-1 and CCL20). Similar effects were obtained in cells stimulated with TNFα or oxLDL. Conversely, siRNA-mediated NOR-1 inhibition significantly increased the expression of pro-inflammatory mediators. Interestingly, in the aortas from transgenic mice that over-express human NOR-1 in VSMC (TgNOR-1), the up-regulation of cytokine/chemokine by LPS was lower compared to wild-type littermates. Similar results were obtained in VSMC from transgenic animals. NOR-1 reduced the transcriptional activity of NFκB sensitive promoters (in transient transfections), and the binding of NFκB to its responsive element (in electrophoretic mobility shift assays). Furthermore, NOR-1 prevented the activation of NFκB pathway by decreasing IκBα phosphorylation/degradation and inhibiting the phosphorylation and subsequent translocation of p65 to the nucleus (assessed by Western blot and immunocytochemistry). These effects were associated with an attenuated phosphorylation of ERK1/2, p38 MAPK and Jun N-terminal kinase, pathways involved in the activation of NFκB. In mouse challenged with LPS, the activation of the NFκB signalling was also attenuated in the aorta from TgNOR-1. Our data support a role for NOR-1 as a negative modulator of the acute response elicited by pro-inflammatory stimuli in the vasculature.
    Original languageEnglish
    Pages (from-to)34-44
    JournalJournal of Molecular and Cellular Cardiology
    Publication statusPublished - 1 Mar 2015


    • Cytokine
    • Gene expression
    • Inflammation
    • NOR-1
    • Vascular smooth muscle cells


    Dive into the research topics of 'NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFκB activation'. Together they form a unique fingerprint.

    Cite this